The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, B.
Right arrow Articles by Brüne, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, B.
Right arrow Articles by Brüne, B.
The Journal of Immunology, 2002, 168: 2828-2834.
Copyright © 2002 by The American Association of Immunologists

Dualism of Oxidized Lipoproteins in Provoking and Attenuating the Oxidative Burst in Macrophages: Role of Peroxisome Proliferator-Activated Receptor-{gamma}1

Barbara Fischer, Andreas von Knethen and Bernhard Brüne2

Faculty of Biology, Department of Cell Biology, University of Kaiserslautern, Kaiserslautern, Germany

Activation and deactivation of macrophages are of considerable importance during the development of various disease states, atherosclerosis among others. Macrophage activation is achieved by oxidized lipoproteins (oxLDL) and is determined by oxygen radical (ROS) formation. The oxidative burst was measured by flow cytometry and quantitated by oxidation of the redox-sensitive dye dichlorodihydrofluorescein diacetate. Short-time stimulation dose-dependently elicited ROS formation. Diphenylene iodonium prevented ROS formation, thus pointing to the involvement of a NAD(P)H oxidase in producing reduced oxygen species. In contrast, preincubation of macrophages with oxLDL for 16 h showed an attenuated oxidative burst upon a second contact with oxLDL. Taking into account that oxLDL is an established peroxisome proliferator-activated receptor-{gamma} (PPAR{gamma}) agonist and considering the anti-inflammatory properties of PPAR{gamma}, we went on and showed that a PPAR{gamma} agonist such as ciglitazone attenuated ROS formation. Along that line, major lipid peroxidation products of oxLDL, such as 9- and 13-hydroxyoctadecadienoic acid, shared that performance. Supporting evidence that PPAR{gamma} activation accounted for reduced ROS generation came from studies in which proliferator-activated receptor response element decoy oligonucleotides, but not a mutated oligonucleotide, supplied in front of oxLDL delivery regained a complete oxidative burst upon cell activation. We conclude that oxLDL not only elicits an oxidative burst upon first contact, but also promotes desensitization of macrophages via activation of PPAR{gamma}. Desensitization of macrophages may have important consequences for the behavior of macrophages/foam cells in atherosclerotic lesions.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. A. Gleissner, J. M. Sanders, J. Nadler, and K. Ley
Upregulation of Aldose Reductase During Foam Cell Formation as Possible Link Among Diabetes, Hyperlipidemia, and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Conway and M. Kinter
Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells
J. Biol. Chem., September 22, 2006; 281(38): 27991 - 28001.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Kohl, S. Preiss, A. von Knethen, and B. Brune
Oxidized low-density lipoprotein depletes PKC{alpha} and attenuates reactive oxygen species formation in monocytes/macrophages
Cardiovasc Res, August 1, 2006; 71(3): 574 - 585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. Rivollier, L. Perrin-Cocon, S. Luche, H. Diemer, J.-M. Strub, D. Hanau, A. van Dorsselaer, V. Lotteau, C. Rabourdin-Combe, T. Rabilloud, et al.
High Expression of Antioxidant Proteins in Dendritic Cells: Possible Implications in Atherosclerosis
Mol. Cell. Proteomics, April 1, 2006; 5(4): 726 - 736.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. J. H. Sachs, K. Hattar, N. Weissmann, R. M. Bohle, T. Weiss, U. Sibelius, and J. Bux
Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model
Blood, February 1, 2006; 107(3): 1217 - 1219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Z. Ma, J. Li, L. Yang, Y. Mu, W. Xie, B. Pitt, and S. Li
Inhibition of LPS- and CpG DNA-induced TNF-{alpha} response by oxidized phospholipids
Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L808 - L816.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Zeng, J. Dai, D. G. Remick, and X. Wang
Homocysteine Mediated Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Monocytes
Circ. Res., August 22, 2003; 93(4): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. A. Shatrov, V. V. Sumbayev, J. Zhou, and B. Brune
Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1{alpha} (HIF-1{alpha}) accumulation via redox-dependent mechanisms
Blood, June 15, 2003; 101(12): 4847 - 4849.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Shashkin, D. Simpson, V. Mishin, B. Chesnutt, and K. Ley
Expression of CXCL16 in Human T Cells
Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 148 - 149.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. von Knethen and B. Brune
Activation of Peroxisome Proliferator-Activated Receptor {gamma} by Nitric Oxide in Monocytes/Macrophages Down-Regulates p47phox and Attenuates the Respiratory Burst
J. Immunol., September 1, 2002; 169(5): 2619 - 2626.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.